Prevention of benzene-induced myelotoxicity by nonsteroidal anti-inflammatory drugs.

Document Type

Article

Publication Date

7-1-1989

Comments

This article has been peer reviewed. It was published in: Environmental health perspectives.

1989 Jul;82:57-64.

The published version is available at PMID: 2792051. Copyright © National Institute of Environmental Health Sciences

Abstract

Benzene affects hematopoietic progenitor cells leading to bone marrow depression and genotoxic effects such as micronucleus formation. Progenitor cell proliferation and differentiation are inhibited by prostaglandins produced by macrophages. Administration of benzene to DBA/2 or C57BL/6 mice caused a dose-dependent bone marrow depression and a significant increase in marrow prostaglandin E level and both were prevented by the coadministration of indomethacin and other inhibitors of the cyclooxygenase component of prostaglandin H synthase. Levels of benzene that decreased bone marrow cellularity also caused genotoxic effects measured as increased micronucleated polychromatic erythrocytes in peripheral blood, which was also prevented by the coadministration of indomethacin. These results suggest a possible role for prostaglandin synthase in benzene myelotoxicity; a mechanism by which this might occur is presented.

PubMed ID

2792051

Link to Full Text

Share

COinS